Senior Faculty News:
Promotions and Appointments
Four senior faculty promotions were announced at a recent meeting of
The Scripps Research Institute (TSRI) Board of Trustees:
- Steven Henriksen, who was promoted to professor in the Department
of Neuropharmacology. Henriksen (B.A., University of California, Santa
Barbara; Ph.D., Stanford University School of Medicine), who joined
the institute in 1983, is interested in discerning the functional organization
of neural circuits where intrinsic capacities for both normal and abnormal
behaviors emerge. To understand how the brain initiates, promotes, and
alters behavior, his research seeks to determine the hierarchical role
that specific central nervous system neuronal circuits and their chemical
messengers have in initiating appropriate complex responses to external
(and internal) sensory events.
- Juan Carlos de la Torre, who was promoted to associate professor
with tenure in the Department of Neuropharmacology. De la Torre (undergraduate
degree, Universidad Autonoma de Madrid, Spain; Ph.D., Centro de Biologia
Molecular Severo Ochoa, Spain) has been at TSRI since 1989. His research
focuses on the molecular and cell biology of the prototypic arenavirus
LCMV and the novel neurotropic agent Borna disease virus and the mechanisms
whereby these viruses persist within the central nervous system, disrupting
normal brain function.
- Nigel Mackman, who was promoted to associate professor with
tenure in the Departments of Immunology and Cell Biology. Mackman (B.Sc.,
Ph.D., University of Leicester, England), joined the institute in 1987
as a research fellow. His laboratory studies the crosstalk between the
coagulation protease cascade and inflammation using human monocytic
cell lines and human monocytes to elucidate the positive and negative
regulatory intracellular signaling networks and transcription factors
that control the expression of procoagulant and inflammatory genes.
In addition, the lab generates transgenic models to examine the role
of these proteins in sepsis and ischemia-reperfusion injury.
- Luc Teyton, was promoted to associate professor with tenure
in the Department of Immunology. Teyton (M.D., Caen Medical School;
Ph.D., University of Paris, France) arrived at TSRI in 1997. His research
focuses on the structure and function of T cell receptor activations,
antigen presentatio, and innate receptor recognition.
In other news about senior faculty, investigator Hugh Rosen has joined
the institute:
- Hugh Rosen, professor in the Department of Immunology, and
chair, Committee for Advanced Human Therapeutics. Rosen (M.D., University
of Cape Town; D.Phil., University of Oxford) studies the regulation
of lymphocyte trafficking and immunosuppression by lysophospholipid
receptor agonists. He uses biological and chemical approaches to suppress
or stimulate the immune response and derive better potential therapies
for transplantation rejection and autoimmune diseases.
Go back to News & Views Index
|
|
